CN108271958A - The fruit vinegar beverage of prevention of cardiovascular disease reducing blood lipid - Google Patents
The fruit vinegar beverage of prevention of cardiovascular disease reducing blood lipid Download PDFInfo
- Publication number
- CN108271958A CN108271958A CN201710008921.6A CN201710008921A CN108271958A CN 108271958 A CN108271958 A CN 108271958A CN 201710008921 A CN201710008921 A CN 201710008921A CN 108271958 A CN108271958 A CN 108271958A
- Authority
- CN
- China
- Prior art keywords
- prevention
- cardiovascular disease
- heated
- added
- blood lipid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 14
- 239000008280 blood Substances 0.000 title claims abstract description 14
- 235000021419 vinegar Nutrition 0.000 title claims abstract description 11
- 235000013399 edible fruits Nutrition 0.000 title claims abstract description 10
- 239000000052 vinegar Substances 0.000 title claims abstract description 10
- 208000024172 Cardiovascular disease Diseases 0.000 title claims abstract description 8
- 235000013361 beverage Nutrition 0.000 title claims abstract description 7
- 230000002265 prevention Effects 0.000 title claims abstract description 7
- 150000002632 lipids Chemical class 0.000 title claims abstract description 6
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 9
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 9
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 9
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 9
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 9
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 9
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 9
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 9
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 9
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 9
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 8
- 239000007788 liquid Substances 0.000 claims abstract description 7
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims abstract description 6
- 239000000463 material Substances 0.000 claims abstract description 6
- 238000002360 preparation method Methods 0.000 claims abstract description 6
- 238000002156 mixing Methods 0.000 claims abstract description 5
- 238000001816 cooling Methods 0.000 claims abstract description 4
- 238000000605 extraction Methods 0.000 claims abstract description 4
- 230000008569 process Effects 0.000 claims abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 4
- 238000000194 supercritical-fluid extraction Methods 0.000 claims abstract description 3
- 240000000171 Crataegus monogyna Species 0.000 claims abstract 2
- 240000000950 Hippophae rhamnoides Species 0.000 claims abstract 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 7
- 235000009508 confectionery Nutrition 0.000 claims description 7
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 6
- 244000298697 Actinidia deliciosa Species 0.000 claims description 5
- 235000009436 Actinidia deliciosa Nutrition 0.000 claims description 5
- 108010011485 Aspartame Proteins 0.000 claims description 3
- YIKYNHJUKRTCJL-UHFFFAOYSA-N Ethyl maltol Chemical compound CCC=1OC=CC(=O)C=1O YIKYNHJUKRTCJL-UHFFFAOYSA-N 0.000 claims description 3
- 229960000583 acetic acid Drugs 0.000 claims description 3
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 3
- 229960003438 aspartame Drugs 0.000 claims description 3
- 235000010357 aspartame Nutrition 0.000 claims description 3
- 239000000605 aspartame Substances 0.000 claims description 3
- 229940093503 ethyl maltol Drugs 0.000 claims description 3
- 235000015203 fruit juice Nutrition 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000011229 interlayer Substances 0.000 claims description 3
- 239000004310 lactic acid Substances 0.000 claims description 3
- 235000014655 lactic acid Nutrition 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 239000001509 sodium citrate Substances 0.000 claims description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 3
- 239000012362 glacial acetic acid Substances 0.000 claims description 2
- 235000021422 persimmon vinegar Nutrition 0.000 claims description 2
- 238000004806 packaging method and process Methods 0.000 abstract description 3
- 235000010082 Averrhoa carambola Nutrition 0.000 abstract 1
- 240000006063 Averrhoa carambola Species 0.000 abstract 1
- 241000381602 Vachellia nebrownii Species 0.000 abstract 1
- 230000017531 blood circulation Effects 0.000 description 8
- 241001092040 Crataegus Species 0.000 description 7
- 230000029087 digestion Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 239000003814 drug Substances 0.000 description 5
- 241000229143 Hippophae Species 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 210000004958 brain cell Anatomy 0.000 description 4
- 208000029078 coronary artery disease Diseases 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 235000009434 Actinidia chinensis Nutrition 0.000 description 2
- 208000027219 Deficiency disease Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- XINCECQTMHSORG-UHFFFAOYSA-N Isoamyl isovalerate Chemical compound CC(C)CCOC(=O)CC(C)C XINCECQTMHSORG-UHFFFAOYSA-N 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003471 anti-radiation Effects 0.000 description 2
- 235000021028 berry Nutrition 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 150000002224 folic acids Chemical class 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 210000005239 tubule Anatomy 0.000 description 2
- 208000032467 Aplastic anaemia Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010021074 Hypoplastic anaemia Diseases 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229940087332 rutin 10 mg Drugs 0.000 description 1
- 230000000192 social effect Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/68—Acidifying substances
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12J—VINEGAR; PREPARATION OR PURIFICATION THEREOF
- C12J1/00—Vinegar; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a kind of fruit vinegar beverage of prevention of cardiovascular disease reducing blood lipid, preparation method is：Select hawthorn, Radix Salviae Miltiorrhizae, using supercritical extraction process method, extraction mixed concentrated liquid and pure water and sea buckthorn juice, carambola juice etc. are stirred uniformly, add relevant auxiliary materials, after mixing, sterilized, cooling, packaging to get.
Description
Technical field
The present invention relates to a kind of fruit vinegar beverages of prevention of cardiovascular disease reducing blood lipid.
Background technology
Cardiovascular disease becomes internationally recognized first killer, and the generation for preventing the disease has whole people's social effect, research
Related product is developed, is used for diet, it is possible to which the incidence for reducing cardiovascular patient is not shown in still currently on the market
The special drink of prevention of cardiovascular patient, fruit vinegar have the function of softening blood vessel, if using fruit vinegar technique, design and prevent painstaking effort
The associated formula of pipe disease produces a kind of fruit vinegar that suitable cardiovascular patient is drunk, it will have broad mass market.
Invention content
The object of the present invention is to provide a kind of fruit vinegar beverages of prevention of cardiovascular disease reducing blood lipid.
The object of the present invention is achieved like this：Stock：1, hawthorn 60%, Radix Salviae Miltiorrhizae 40% are selected, using supercritical extract
Process, extraction mixed concentrated liquid are spare；2, sea buckthorn juice 50%, kiwi-fruit juice 50% are taken, it is spare after mixing；It makes：1、
It is prepared in 92% ratio, takes pure water 500kg, account for 92% ratio, be placed in interlayer material-compound tank, heated by boiler, to matching
When batch can heats 40 DEG C, the mixed concentrated liquid 4% that material preparation step 1 obtains is added, is roughly equal to 22kg, the mixing that material preparation step 2 obtains
Fruit juice 4%, is roughly equal to 22kg, stirs evenly；2, take Aspartame 0.06kg, ethylmaltol 0.06kg, fresh and sweet element 0.12kg mixed
It closes uniformly, dissolving is added in tank, then takes citric acid 1.9kg, sodium citrate 1.3kg, lactic acid 400ml, glacial acetic acid 150ml, persimmon
Material-compound tank is added in vinegar 400ml dissolvings, after stirring evenly, when being heated up to 60 DEG C, adds flavoring apple essence 500ml, color protection element
0.2kg is stirred evenly, and when being heated up to 80 DEG C again, is sterilized, canned sealing, cooling, packaging to get.
The positive effect of the present invention is：Hawthorn：It is sour sweet, slightly warm in nature, promoting digestion and removing indigestion, promoting blood circulation to remove blood stasis, this product it is sour and
Sweet, tepor is not hot, and work(, which is arrogated to oneself, helps spleen stomach invigorating, promotes digestion, for the key medicine for the greasy meat stagnation that disappears, does not change for food stagnation, carnivorous, product
It is stagnant not disappear, abdominal distention, lochiorrhagia and stasis dysmenorrhoea etc..In recent years clinical often with raw hawthorn for high blood pressure, coronary heart disease and
The treatment of hyperlipidemia.Radix Salviae Miltiorrhizae；It activates blood circulation and disperses blood clots, activating blood circulation and reducing swelling, nourishing blood and tranquilization is treatment heart disease, coronary heart disease key medicine, uses in recent years
Control hypoplastic anemia, granular white blood cells deficiency disease.Sea-buckthorn：It is promoting blood circulation and removing blood stasis, it helps digestion, anti-oxidant, anti-radiation effect, containing big
The VC of amount is the important source material for supplementing natural VC, and VC, which is also one of important substance in brain and calcium combination, can play brilliance
Brain strengthening function, and containing compositions such as a large amount of flavonoids, folic acid class, glucose, fructose.Kiwi berry：Wound can be promoted to heal, enhanced
Resistance and other hormones reflect together increases curative effect, and anti-aging, anti-oxidant, anticancer, there are data to show internal VC levels
Gao Shi, life span extension.VC plays quite big in terms of the relaxation and deflation firm, that eliminate brain cell that promote brain cell structure
Effect.U.S. nutritionist sums up conclusion：There is very close relationship between the content and intelligence of VC in the blood of people,
Neural tubule permeability can be enhanced, improve cerebral function, kept resourceful.
Specific implementation mode
Embodiment and drug action mechanism is described in detail in combined formulation.
Stock：1, hawthorn 60%, Radix Salviae Miltiorrhizae 40% are selected, using supercritical extraction process method, extraction mixed concentrated liquid is standby
With；2, sea buckthorn juice 50%, kiwi-fruit juice 50% are taken, it is spare after mixing；
It makes：1, it is prepared in 92% ratio, takes pure water 500kg, account for 92% ratio, be placed in interlayer material-compound tank, led to
Boiler heating is crossed, when heating 40 DEG C to material-compound tank, the mixed concentrated liquid 4% that material preparation step 1 obtains is added, is roughly equal to 22kg, stocks up
The blended fruit juice 4% that step 2 obtains, is roughly equal to 22kg, stirs evenly；2, Aspartame 0.06kg, ethylmaltol 0.06kg are taken,
Fresh and sweet element 0.12kg is uniformly mixed, and dissolving is added in tank, then takes citric acid 1.9kg, sodium citrate 1.3kg, lactic acid 400ml, ice
Material-compound tank is added in acetic acid 150ml, persimmon vinegar 400ml dissolvings, after stirring evenly, is heated up to 60.DEG C when, add flavoring apple essence
500ml, color protection element 0.2kg, stir evenly, when being heated up to 80 DEG C again, are sterilized, canned sealing, cooling, packaging to get.
Hawthorn：Sour sweet, slightly warm in nature, promoting digestion and removing indigestion, promoting blood circulation to remove blood stasis, this product is sour and sweet, and tepor is not hot, and work(, which is arrogated to oneself, helps spleen strong
Stomach promotes digestion, for the key medicine for the greasy meat stagnation that disappears, does not change for food stagnation, and carnivorous, stagnant not disappear, abdominal distention, lochia is not
Most and stasis dysmenorrhoea etc..In recent years the clinical treatment that high blood pressure, coronary heart disease and hyperlipidemia are often used for raw hawthorn
Radix Salviae Miltiorrhizae：Activate blood circulation and disperse blood clots, activating blood circulation and reducing swelling, nourishing blood and tranquilization, be treatment heart disease, coronary heart disease key medicine, in recent years with control regenerate
Not benign anaemia, granular white blood cells deficiency disease.
Sea-buckthorn：It is promoting blood circulation and removing blood stasis, it helps digestion, anti-oxidant, anti-radiation effect is the important of the natural VC of supplement containing a large amount of VC
Raw material, VC, which is also one of important substance in brain and calcium combination, can play remarkable brain strengthening function, and containing a large amount of flavonoids,
The compositions such as folic acid class, glucose, fructose.
Kiwi berry：Wound can be promoted to heal, resistance building and other hormones reflect together increase curative effect, anti-aging,
Anti-oxidant, anticancer, when high there are data to show internal VC levels, life span extension.VC promote brain cell structure it is firm,
Sizable effect is played in terms of the relaxation and deflation of eliminating brain cell.U.S. nutritionist sums up conclusion：In the blood of people
There is very close relationship between the content and intelligence of VC, neural tubule permeability can be enhanced, improve cerebral function, keeps thinking
Dimension is quick.
Through examining the beneficiating ingredient in 100g fruit vinegars as follows：
| Hawthorn total saposins | ≥1.5g | Calcium | 2.5mg |
| Rutin | 10mg | Iron | 5.0mg |
| Radix Salviae Miltiorrhizae general flavone | 30mg | Unsaturated fatty acid | 10.25mg |
| Vitamin c | 150mg | Methionine | 14.5mg |
| Tryptophan | 20.4mg | Valine | 11.7mg |
| Lysine | 9.1mg | Leucine | 13.1mg |
| Glutamic acid | 17.3mg | Phenylalanine | 16.5mg |
| Carrotene | 5mg | Serine | 10.5mg |
| Arginine | 10.25mg | Glycine | 7.5mg |
| Histidine | 15.4mg | Vitamin B1 | 0.67mg |
By examining, the above ingredient is beneficial to cardiovascular disease and is drunk as auxiliary beverage.
Claims (1)
1. a kind of fruit vinegar beverage of prevention of cardiovascular disease reducing blood lipid, preparation method are：Stock：1, hawthorn 60%, Radix Salviae Miltiorrhizae are selected
40%, using supercritical extraction process method, extraction mixed concentrated liquid is spare；2, sea buckthorn juice 50%, kiwi-fruit juice 50% are taken,
It is spare after mixing；It makes：1, it is prepared in 92% ratio, takes pure water 500kg, account for 92% ratio, be placed in interlayer material-compound tank,
It is heated by boiler, when heating 40 DEG C to material-compound tank, the mixed concentrated liquid 4% that material preparation step 1 obtains is added, is roughly equal to 22kg, it is standby
Expect the blended fruit juice 4% that step 2 obtains, is roughly equal to 22kg, stirs evenly；2, Aspartame 0.06kg, ethylmaltol are taken
0.06kg, fresh and sweet element 0.12kg are uniformly mixed, and dissolving is added in tank, then takes citric acid 1.9kg, sodium citrate 1.3kg, lactic acid
Material-compound tank is added in 400ml, glacial acetic acid 150ml, persimmon vinegar 400ml dissolvings, after stirring evenly, when being heated up to 60 DEG C, adds apple
Fruity essence 500ml, color protection element 0.2kg, stir evenly, when being heated up to 80 DEG C again, are sterilized, canned sealing, cooling, packet
Dress to get.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710008921.6A CN108271958A (en) | 2017-01-06 | 2017-01-06 | The fruit vinegar beverage of prevention of cardiovascular disease reducing blood lipid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710008921.6A CN108271958A (en) | 2017-01-06 | 2017-01-06 | The fruit vinegar beverage of prevention of cardiovascular disease reducing blood lipid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108271958A true CN108271958A (en) | 2018-07-13 |
Family
ID=62800850
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710008921.6A Pending CN108271958A (en) | 2017-01-06 | 2017-01-06 | The fruit vinegar beverage of prevention of cardiovascular disease reducing blood lipid |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108271958A (en) |
-
2017
- 2017-01-06 CN CN201710008921.6A patent/CN108271958A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105639014B (en) | A kind of polypeptide beverage and preparation method thereof | |
| CN107149068A (en) | A kind of honey sobering-up beverage and preparation method thereof | |
| CN103829256B (en) | Beverage and the production method thereof of fused phytosterol | |
| EP3673038A1 (en) | A method for producing a polyphenolic composition from barley malt | |
| CN102366141B (en) | Technological method for manufacturing fruit vinegar beverage by use of edible mushrooms | |
| CN102366142B (en) | Acanthopanax fruit vinegar beverage | |
| CN102429279B (en) | Hawthorn fruit vinegar beverage | |
| CN102429280B (en) | Fruit vinegar beverage favorable for woman complexion | |
| CN102429282A (en) | Salsola collina fruit-vinegar beverage | |
| JP2002272430A (en) | Health beverage | |
| CN108271958A (en) | The fruit vinegar beverage of prevention of cardiovascular disease reducing blood lipid | |
| CN103789116A (en) | Dealcoholized haw wine | |
| CN106720782A (en) | A kind of jujube ginger tea | |
| CN102366138B (en) | Schisandra fruit vinegar beverage | |
| CN106901082A (en) | Sea-buckthorn chitin prevents three beverages high | |
| CN109198311A (en) | A kind of liquid for sobering up made of flower of kudzuvine sea-buckthorn | |
| CN102367412B (en) | Method for preparing special fruit vinegar by adopting oriental wormwood | |
| CN104886679A (en) | Persimmon leaf, tea and fruit vinegar beverage | |
| CN105011253A (en) | Fruit vinegar beverage capable of lowering blood lipid | |
| CN106819674A (en) | A kind of carambola flower tea fruit vinegar beverage | |
| CN109105582A (en) | A kind of flower of kudzuvine is relieved the effect of alcohol fruit vinegar beverage | |
| CN106166279A (en) | A kind of blood-activating analgetic treatment gastric ulcer medicated tea and preparation processing method | |
| CN105077421A (en) | Manufacturing method for characteristic fruit vinegar by using Artemisia capillaris | |
| CN104187936A (en) | Method of preparing fruit vinegar beverage for preventing hypertension, hyperlipemia and hyperglycaemia from okra and gynostemma pentaphylla | |
| CN102422932A (en) | Fruit vinegar beverage assisting in relieving hangover |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180713 |
|
| WD01 | Invention patent application deemed withdrawn after publication |